Anke Faehnrich

Jan 10, 2024 | biorxiv.org | Karosham Diren Reddy |Fabian Ott |Anke Faehnrich |Yamil Maluje

AbstractPost-COVID syndrome (PCS) currently affects approximately 3-17% of people following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and has the potential to become a significant global health burden. PCS presents with various symptoms, and methods for improved PCS assessment are presently developed to guide therapy. Nevertheless, there are few mechanistic insights and treatment options.